All In MedTech

Device Trial Radar · NCT07091773

A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty

A Clinical Trial to Evaluate the Safety and Effectiveness of "OLIZ," a Combined Wavelength Photobiomodulation Medical Device, for Surgical Site Pain Relief in Patients Who Have Undergone Total Knee Arthroplasty (TKA) : A Multicenter, Controlled, and Randomized Clinical Trial

Last checked: Nov 19, 2026Latest source record: Jul 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

68

Planned (sponsor's estimate)

Start

Aug 20, 2025

Primary completion

Jan 30, 2026

Study completion Jun 30, 2026

Sponsor

Lead sponsor
LTBIO Co., Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
Inje University; InjeUniversityIlsanPaikHospital; Gangnam Severance Hospital; National Medical Center, Seoul; National Health Insurance Service Ilsan Hospital; Korea University Anam Hospital; Samsung Medical Center; The Catholic University of Korea Uijeongbu St.Marys Hostpial
First posted
Jul 29, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 19 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty

Conditions

  • Postoperative Pain Management During Rehabilitation in Patients Undergoing Total Knee Arthroplasty

Interventions

  • OLIZ Photobiomodulation DeviceDevice

    OLIZ device utilizes dual-wavelength technology combining specific red (660nm) and near-infrared (850nm) light parameters optimized for post-surgical tissue healing. The device features controlled power density, precise treatment duration protocols, and targeted application to knee arthroplasty surgical sites. Treatment parameters include specific irradiance levels, treatment session duration of 15 minutes, and 3 times of daily application frequency designed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in VAS Pain ScoreTime frame: Baseline and 11 weeks post-baseline

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.